In the past 50 years, only one new tuberculosis drug has come on to the market, yet many more active substances are urgently needed. Current treatments increasingly fail due to multidrug-res... Read more
Researchers at Rice, Tel Aviv and Johns Hopkins universities aim to break cancer’s codes for social networking In the face of mounting evidence that cancer cells communicate, cooperate and e... Read more
Kills 2 million people annually A two-drug combination is one of the most promising advances in decades for the treatment of tuberculosis (TB) — a disease that kills 2 million people a... Read more